Johnson & Johnson Price to Book Ratio 2006-2018 | JNJ
Historical price to book ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current price to book ratio for Johnson & Johnson as of February 18, 2019 is 5.66.
| Johnson & Johnson Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2019-02-15 |
136.38 |
|
5.66 |
| 2018-09-30 |
137.30 |
$24.09 |
5.70 |
| 2018-06-30 |
119.77 |
$23.45 |
5.11 |
| 2018-03-31 |
125.57 |
$23.58 |
5.32 |
| 2017-12-31 |
136.04 |
$22.43 |
6.07 |
| 2017-09-30 |
125.82 |
$27.55 |
4.57 |
| 2017-06-30 |
127.21 |
$26.78 |
4.75 |
| 2017-03-31 |
118.99 |
$26.10 |
4.56 |
| 2016-12-31 |
109.35 |
$26.02 |
4.20 |
| 2016-09-30 |
111.35 |
$26.73 |
4.17 |
| 2016-06-30 |
113.58 |
$26.47 |
4.29 |
| 2016-03-31 |
100.60 |
$26.40 |
3.81 |
| 2015-12-31 |
94.82 |
$25.82 |
3.67 |
| 2015-09-30 |
85.55 |
$25.86 |
3.31 |
| 2015-06-30 |
88.62 |
$25.69 |
3.45 |
| 2015-03-31 |
90.81 |
$24.45 |
3.71 |
| 2014-12-31 |
93.74 |
$25.06 |
3.74 |
| 2014-09-30 |
94.93 |
$27.31 |
3.48 |
| 2014-06-30 |
92.55 |
$27.65 |
3.35 |
| 2014-03-31 |
86.30 |
$27.08 |
3.19 |
| 2013-12-31 |
79.89 |
$26.25 |
3.04 |
| 2013-09-30 |
75.09 |
$24.75 |
3.03 |
| 2013-06-30 |
73.82 |
$24.75 |
2.98 |
| 2013-03-31 |
69.57 |
$23.85 |
2.92 |
| 2012-12-31 |
59.34 |
$23.33 |
2.54 |
| 2012-09-30 |
57.83 |
$23.08 |
2.51 |
| 2012-06-30 |
56.19 |
$21.97 |
2.56 |
| 2012-03-31 |
54.33 |
$22.35 |
2.43 |
| 2011-12-31 |
53.55 |
$20.95 |
2.56 |
| 2011-09-30 |
51.53 |
$22.52 |
2.29 |
| 2011-06-30 |
53.34 |
$22.67 |
2.35 |
| 2011-03-31 |
47.10 |
$21.86 |
2.15 |
| 2010-12-31 |
48.73 |
$20.66 |
2.36 |
| 2010-09-30 |
48.40 |
$20.85 |
2.32 |
| 2010-06-30 |
45.70 |
$19.19 |
2.38 |
| 2010-03-31 |
50.00 |
$19.19 |
2.61 |
| 2009-12-31 |
49.01 |
$18.37 |
2.67 |
| 2009-09-30 |
45.97 |
$18.27 |
2.52 |
| 2009-06-30 |
42.54 |
$16.79 |
2.53 |
| 2009-03-31 |
39.05 |
$15.87 |
2.46 |
| 2008-12-31 |
44.05 |
$15.35 |
2.87 |
| 2008-09-30 |
50.60 |
$16.45 |
3.08 |
| 2008-06-30 |
46.70 |
$16.61 |
2.81 |
| 2008-03-31 |
46.75 |
$16.19 |
2.89 |
| 2007-12-31 |
47.76 |
$15.25 |
3.13 |
| 2007-09-30 |
46.75 |
$15.17 |
3.08 |
| 2007-06-30 |
43.56 |
$14.90 |
2.92 |
| 2007-03-31 |
42.32 |
$14.14 |
2.99 |
| 2006-12-31 |
46.09 |
$13.59 |
3.39 |
| 2006-09-30 |
45.08 |
$13.97 |
3.23 |
| 2006-06-30 |
41.36 |
$13.89 |
2.98 |
| 2006-03-31 |
40.62 |
$13.83 |
2.94 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$365.894B |
$81.581B |
|
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
|
